Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial
Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now displays Revision: v3.3.2 instead of Revision: v3.2.0. This reflects a site update/versioning detail.SummaryDifference0.1%

- Check28 days agoChange DetectedThe notice about government funding operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe changes appear limited to administrative updates (e.g., last update date) with no modifications to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference4%

- Check78 days agoChange DetectedUpdated canonical name to Glycogen storage disease II and bumped revision to v3.1.0, replacing the prior Glycogen storage disease ii and v3.0.2.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page metadata has been updated to version v3.0.2 with new date stamps (2025-09-11, 2025-09-09, 2025-09) and an 'Estimated' last update label, replacing older v3.0.1 metadata from 2018. No substantive changes to core content (pricing, stock, or time slots) were detected.SummaryDifference1%

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.